Bayer HealthCare / Press

New Phase 3 Study in China Confirms Vision Improvement for Patients with Wet Age-Related Macular Degeneration when Receiving Aflibercept Solution for Intravitreal Injection

Bayer HealthCare announced the primary outcomes of the Phase 3 SIGHT study at the 30th Asia-Pacific Academy of Ophthalmology Congress in Guangzhou, China. more      

In Focus

Healthcare News

Photos & Videos

  • Photos

    Photo galleries with topic-related images.
    more

  • TV Footage

    In this section you can find videos for editorial coverage. » more

    Videos

    The video section provides an overview of interesting videos for viewing. » more

Bayer HealthCare Links

RSS Feed
RSS Feed

http://press.healthcare.bayer.com/en/press/index.php

Copyright © Bayer HealthCare AG